NEXGEL, Inc. (NASDAQ:NXGL) CEO Adam R. Levy Sells 4,000 Shares

NEXGEL, Inc. (NASDAQ:NXGL) CEO Adam R. Levy sold 4,000 shares of the business’s stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $3.16, for a total transaction of $12,640.00. Following the sale, the chief executive officer now directly owns 374,284 shares of the company’s stock, valued at $1,182,737.44. This represents a 1.06 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

NEXGEL Stock Up 2.5 %

Shares of NXGL opened at $2.84 on Thursday. The company has a current ratio of 1.51, a quick ratio of 0.93 and a debt-to-equity ratio of 0.19. The firm has a fifty day moving average price of $3.52 and a 200-day moving average price of $3.26. The firm has a market capitalization of $19.29 million, a P/E ratio of -4.90 and a beta of 0.57. NEXGEL, Inc. has a 12-month low of $1.84 and a 12-month high of $5.10.

Hedge Funds Weigh In On NEXGEL

A number of large investors have recently added to or reduced their stakes in the company. Virtu Financial LLC acquired a new position in shares of NEXGEL during the fourth quarter valued at about $48,000. IFP Advisors Inc acquired a new position in shares of NEXGEL during the fourth quarter valued at about $49,000. Two Sigma Securities LLC acquired a new position in shares of NEXGEL during the fourth quarter valued at about $54,000. Northeast Financial Group Inc. increased its holdings in shares of NEXGEL by 168.8% during the third quarter. Northeast Financial Group Inc. now owns 31,848 shares of the company’s stock valued at $82,000 after acquiring an additional 20,000 shares in the last quarter. Finally, Geode Capital Management LLC boosted its position in NEXGEL by 5.8% in the fourth quarter. Geode Capital Management LLC now owns 60,142 shares of the company’s stock valued at $268,000 after buying an additional 3,302 shares during the last quarter. 2.21% of the stock is currently owned by institutional investors.

NEXGEL Company Profile

NEXGEL, Inc manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc and changed its name to NEXGEL, Inc in November 2019.